Neptune Technologies & Bioresources Inc Competitors

NEPT 
$2
*  
0.11
5.82%
Get NEPT Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading NEPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NEPT After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Neptune Technologies & Bioresources Inc
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 423.79 12.80 ▲ 732,852 $ 424.44
$ 412.3956
$ 437.6384
$ 257.69
143.17 41,992,079,730
Intercept Pharmaceuticals, Inc.
ICPT: NASDAQ-GS
$ 150.14 9.43 ▲ 663,772 $ 150.50
$ 143.75
$ 497
$ 54.02
NE 3,185,670,520
Taro Pharmaceutical Industries Ltd.
TARO: NYSE
$ 147.23 9.30 ▲ 90,764 $ 147.41
$ 140.23
$ 168.99
$ 93
16.14 6,306,155,360
Ovascience Inc.
OVAS: NASDAQ-GM
$ 43.22 8.26 ▲ 1,972,672 $ 49.94
$ 41.96
$ 36.54
$ 5.509
NE 1,048,949,400
Puma Biotechnology Inc
PBYI: NYSE
$ 208.66 7.32 ▲ 243,900 $ 210.69
$ 200.0035
$ 279.37
$ 53.63
NE 6,290,681,680
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 188.96 6.88 ▲ 1,289,590 $ 189.01
$ 184
$ 203.30
$ 122.69
78.73 37,379,122,400
Vertex Pharmaceuticals Incorporated
VRTX: NASDAQ-GS
$ 117.74 5.89 ▲ 2,133,244 $ 118.67
$ 111.66
$ 122.26
$ 59.79
NE 28,031,774,680
Perrigo Company
PRGO: NYSE
$ 164.85 5.70 ▲ 1,611,624 $ 164.92
$ 158.39
$ 168.39
$ 125.37
138.53 22,082,646,600
Shire plc
SHPG: NASDAQ-GS
$ 220.88 5.63 ▲ 890,609 $ 221.20
$ 217.50
$ 264.98
$ 136.29
33.52 132,214,792,160
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 38 4.81 ▲ 1,528,857 $ 39.50
$ 37.45
$ 33.22
$ 8.01
NE 1,161,280,000
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 91.83 4.62 ▲ 1,415,339 $ 91.85
$ 88.12
$ 96.355
$ 55.04
NE 13,509,754,110
MacroGenics, Inc.
MGNX: NASDAQ-GS
$ 33.83 4.58 ▲ 1,562,144 $ 35.58
$ 28.23
$ 41
$ 17.31
NE 938,410,370
Receptos, Inc.
RCPT: NASDAQ-GS
$ 127.89 4.30 ▲ 569,467 $ 128.35
$ 125.05
$ 135.37
$ 24.5345
NE 3,488,711,310
Allergan, Inc.
AGN: NYSE
$ 212.18 4.15 ▲ 2,834,211 $ 213.61
$ 209.545
$ 214.66
$ 98.78
49.46 63,208,209,820
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 54.96 4.08 ▲ 509,330 $ 54.99
$ 52.60
$ 56.99
$ 14.51
NE 1,819,340,880
Salix Pharmaceuticals, Ltd.
SLXP: NASDAQ-GS
$ 118.45 3.96 ▲ 2,489,914 $ 121.51
$ 112.73
$ 172.98
$ 83.26
NE 7,543,962,050
Celgene Corporation
CELG: NASDAQ-GS
$ 116.48 3.66 ▲ 6,089,113 $ 116.5017
$ 114.56
$ 119.84
$ 66.85
60.98 93,126,924,800
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 119.72 3.64 ▲ 850,086 $ 120
$ 115.0407
$ 124.3899
$ 21.01
NE 4,125,311,760
United Therapeutics Corporation
UTHR: NASDAQ-GS
$ 131.11 3.61 ▲ 608,223 $ 133.35
$ 127.60
$ 137.84
$ 84.63
38.56 6,197,438,590
Immune Design Corp.
IMDZ: NASDAQ-GM
$ 27.44 3.60 ▲ 32,521 $ 27.81
$ 24.09
$ 36.69
$ 11.51
NE 463,159,760
Insys Therapeutics, Inc.
INSY: NASDAQ-GM
$ 46.69 3.56 ▲ 878,282 $ 47.169
$ 43.05
$ 57.9133
$ 20.52
32.13 1,611,271,900
Karyopharm Therapeutics Inc.
KPTI: NASDAQ-GS
$ 36.12 3.51 ▲ 374,889 $ 36.34
$ 32.95
$ 49.005
$ 21.13
NE 1,180,040,400
Jazz Pharmaceuticals plc
JAZZ: NASDAQ-GS
$ 169.88 3.48 ▲ 585,416 $ 170.55
$ 167.09
$ 183.84
$ 110.675
395.07 10,230,343,480
Valeant Pharmaceuticals International, Inc.
VRX: NYSE
$ 143 3.00 ▲ 2,206,540 $ 143.50
$ 139.53
$ 153.10
$ 106
97.28 48,001,239,000
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 99.41 2.96 ▲ 517,614 $ 99.52
$ 96.83
$ 112.57
$ 47.03
NE 7,590,450,550